Results 241 to 250 of about 6,805,202 (337)

Dendrimer Conjugates with PD‐L1‐Binding Peptides Enhance In Vivo Antitumor Immune Response

open access: yesAdvanced Healthcare Materials, EarlyView.
In this paper, a novel nanoparticle scaffold composed of dendrimers conjugated with peptide‐based immune checkpoint inhibitors, enhancing drug delivery efficacy is introduced. By conjugating PD‐L1‐binding peptides to dendrimers, multivalent binding effects are harnessed, resulting in enhanced binding affinity, prolonged half‐life, and improved ...
DaWon Kim   +11 more
wiley   +1 more source

A Modular Cloning Toolkit for the production of recombinant proteins in Leishmania tarentolae. [PDF]

open access: yesMicrob Cell
Hieronimus K   +20 more
europepmc   +1 more source

Combination of Recombinant Proteins S1/N and RBD/N as Potential Vaccine Candidates. [PDF]

open access: yesVaccines (Basel), 2023
Mendoza-Ramírez NJ   +12 more
europepmc   +1 more source

Expression and analysis of recombinant Amb a V and Amb t V allergens. Comparison with native proteins by immunological assays and NMR spectroscopy.

open access: hybrid, 1992
Þórunn Rafnar   +6 more
openalex   +1 more source

Geometric Adjustment of T Cell‐Sensitive Nanorobots for Enhanced Stability

open access: yesAdvanced Healthcare Materials, EarlyView.
For the long‐term use of live dendritic cell (DC)‐based vaccines, nano bone marrow dendritic cell (BMDC) originated T cell activators (nano‐BOTs) are synthesized. The geometric properties of nanoparticles are precisely modulated, enhancing their stability and T cell activation capacity.
Yoojin Lee   +11 more
wiley   +1 more source

Isolation of a cDNA fragment coding for Chlamydomonas reinhardtii ferredoxin and expression of the recombinant protein in Escherichia coli

open access: green, 1992
William J. Rogers   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy